Pembrolizumab in relapsed or refractory primary mediastinal large b-cell lymphoma

  1. Armand, P.
  2. Rodig, S.
  3. Melnichenko, V.
  4. Thieblemont, C.
  5. Bouabdallah, K.
  6. Tumyan, G.
  7. Özcan, M.
  8. Portino, S.
  9. Fogliatto, L.
  10. Caballero, M.D.
  11. Walewski, J.
  12. Gulbas, Z.
  13. Ribrag, V.
  14. Christian, B.
  15. Perini, G.F.
  16. Salles, G.
  17. Svoboda, J.
  18. Zain, J.
  19. Patel, S.
  20. Chen, P.-H.
  21. Ligon, A.H.
  22. Ouyang, J.
  23. Neuberg, D.
  24. Redd, R.
  25. Chatterjee, A.
  26. Balakumaran, A.
  27. Orlowski, R.
  28. Shipp, M.
  29. Zinzani, P.L.
  30. Show all authors +
Journal:
Journal of Clinical Oncology

ISSN: 1527-7755,  0732-183X

Year of publication: 2019

Volume: 37

Issue: 34

Pages: 3291-3299

Type: Conference paper

DOI: 10.1200/JCO.19.01389 GOOGLE SCHOLAR lock_openOpen access editor
Data source: Scopus